Trans-sodium crocetinate does not affect oxygen uptake in rats during treadmill running

Area of Science:

• Biochemistry
• Exercise Physiology
• Pharmacology

Background:

• Trans-sodium crocetinate (TSC), a derivative of crocetin, enhances survival in hemorrhagic shock by restoring physiological parameters.
• The proposed mechanism involves increased oxygen diffusivity in plasma, potentially improving oxygen availability.
• This suggests a possible role for TSC in enhancing oxygen utilization during physiological stress like exercise.

Purpose of the Study:

• To investigate the effect of Trans-sodium crocetinate (TSC) on oxygen consumption and exercise performance in rats.
• To determine if TSC administration alters oxygen transfer to skeletal muscle mitochondria during exercise.
• To elucidate the impact of TSC on maximal oxygen uptake (VO2max) and running capacity.

Main Methods:

• Male Sprague-Dawley rats received intravenous injections of TSC or a placebo.
• Animals underwent a ramped treadmill test protocol to assess exercise performance.
• Submaximal and maximal oxygen consumption (VO2 and VO2max) were measured during the exercise test.

Main Results:

• Trans-sodium crocetinate (TSC) administration had no significant effect on submaximal or maximal oxygen consumption (VO2max).
• Running performance, including maximal running time and aerobic velocity, was not improved by TSC.
• The study found no evidence of enhanced oxygen utilization in rats treated with TSC during exhaustive exercise.

Conclusions:

• Trans-sodium crocetinate (TSC) does not appear to enhance oxygen consumption or exercise performance in healthy rats.
• The proposed mechanism of increased oxygen diffusivity by TSC may not translate to improved aerobic capacity.
• Further research is needed to understand the physiological effects of TSC during exercise.